Title : Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma.

Pub. Date : 2017 May 22

PMID : 28530704






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma. Dehydroepiandrosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 Cytochrome P450 17A1 (CYP17A1), which converts pregnenolone to dehydroepiandrosterone (DHEA) in endocrine organs and the brain, is required for prostate cancer progression and acquired chemotherapeutic resistance. Dehydroepiandrosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
3 Cytochrome P450 17A1 (CYP17A1), which converts pregnenolone to dehydroepiandrosterone (DHEA) in endocrine organs and the brain, is required for prostate cancer progression and acquired chemotherapeutic resistance. Dehydroepiandrosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
4 Cytochrome P450 17A1 (CYP17A1), which converts pregnenolone to dehydroepiandrosterone (DHEA) in endocrine organs and the brain, is required for prostate cancer progression and acquired chemotherapeutic resistance. Dehydroepiandrosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
5 Cytochrome P450 17A1 (CYP17A1), which converts pregnenolone to dehydroepiandrosterone (DHEA) in endocrine organs and the brain, is required for prostate cancer progression and acquired chemotherapeutic resistance. Dehydroepiandrosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
6 However, whether CYP17A1-mediated DHEA synthesis is involved in brain tumor malignancy, especially in glioma, the most prevalent brain tumor, is unknown. Dehydroepiandrosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
7 To investigate the role of CYP17A1 in glioma, we determined that CYP17A1 expression is significantly increased in gliomas, which secrete more DHEA than normal astrocytes. Dehydroepiandrosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
8 Together, our results suggest that components of the Sp1-CYP17A1-DHEA axis, which promotes the development of TMZ resistance, may serve as potential biomarkers and therapeutic targets in recurrent glioma. Dehydroepiandrosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens